| CEO: | Sean M. Smith |
| CFO: | Alexander John Abrey |
| Non-Executive Chairman: | Lykele van der Broek |
| Non-Executive Dir: | Derek McAllan, Robin James Scott Cridland |
| Address: | 67C Innovation Drive, Milton Park, Abingdon, Oxfordshire, England, United Kingdom, OX14 4RQ |
| Website: | http://www.edenresearch.com/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0001646941 |
| Currency | UK Pounds |
| Share Price | 3.10p |
| Change Today | 0.40p |
| % Change | 14.81 % |
| 52 Week High | 4.25 |
| 52 Week Low | 2.10 |
| Volume | 2,566,391 |
| Shares Issued | 533.35m |
| Market Cap | £16.53m |
| Beta | 0.81 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:20 | 14,983 @ 2.90p |
| 15:54 | 50,000 @ 3.16p |
| 15:53 | 7,273 @ 3.30p |
| 15:06 | 122,013 @ 2.95p |
| 15:05 | 100,000 @ 3.17p |
| CFO | Alexander John Abrey |
| CEO | Sean M. Smith |
You are here: research